New drug AK0406 takes first step: safety check in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study tests a new drug, AK0406, in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose of either the drug or a placebo. The goal is to gather initial safety information before testing in patients.
Phase: PHASE1 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 09:08 UTC